Regenerative peripheral nerve interfaces (RPNIs): current status and future direction

Current Status and Future Direction of the Monk Software Package

The MONK user package comprises not only the Monte Carlo code itself but also nuclear data libraries, validation data, documentation, geometry model visualisation tools, productivity tools of various kinds and user support services. In identifying the development direction for the package, input is obtained not only from the two collaborating partners but also from others customers of the ANSWE...

PET/MR imaging: current status and future direction

PET/CT has emerged as an important tool in oncology to detect, characterize, and follow-up various tumor entities. The integrated technology includes the respective advantageousness of PET and CT in a synergistic manner combining high sensitivity of PET with transmission correction and anatomic referencing by CT. PET/CT has been proven to be fast, robust and meanwhile widely available in oncolo...

The current status and future direction of fetal gene therapy

Anna L David, Michael Themis, Simon N Waddington, Lisa Gregory, Suzanne MK Buckley, Megha Nivsarkar, Terry Cook, Donald Peebles, Charles H Rodeck, Charles Coutelle Department of Obstetrics and Gynaecology, Royal Free and University College London Medical School, London WC1E 6HX Gene Therapy Research Group, Section of Cell and Molecular Biology, Division of Biomedical Sciences, Imperial College ...

Current Status and Future Direction of Transcatheter Mitral Valve Replacement

Targeted therapy for hepatocellular carcinoma: current status and future direction

Following the proof of evidence on the use of sorafenib in patients with advanced hepatocellular carcinoma (HCC), targeted therapy has become an important element in management of advanced HCC. Novel targeted therapies are designed to inhibit the aberrant signaling pathways or oncogenic mechanism at a molecular level with an aim to improve the clinical outcome. An increasing number of targeted ...